ArticleCells2024

Modulating Cholesterol Metabolism via ACAT1 Knockdown Enhances Anti-B-Cell Lymphoma Activities of CD19-Specific Chimeric Antigen Receptor T Cells by Improving the Cell Activation and Proliferation.

Qiong Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.